<SEC-DOCUMENT>0001121404-24-000003-index.html : 20240201
<SEC-HEADER>0001121404-24-000003.hdr.sgml : 20240201
<ACCEPTANCE-DATETIME>20240201094514
ACCESSION NUMBER:		0001121404-24-000003
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240201
DATE AS OF CHANGE:		20240201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanofi
		CENTRAL INDEX KEY:			0001121404
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				133529324
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31368
		FILM NUMBER:		24585281

	BUSINESS ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017
		BUSINESS PHONE:		33153774400

	MAIL ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI-AVENTIS
		DATE OF NAME CHANGE:	20040826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI SYNTHELABO SA
		DATE OF NAME CHANGE:	20010104
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6kcoverpagepressreleaseq4.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: a6kcoverpagepressreleaseq4.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressreleaseq42023english.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: pressreleaseq42023english.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>capturedecran2024-01x23a18a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: capturedecran2024-01x23a18a.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>chart-22b986bd4a964014b65a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: chart-22b986bd4a964014b65a.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>imagea.jpg
<TEXT>
Document 5 - file: imagea.jpg

</DOCUMENT>
</SEC-DOCUMENT>